Table 2.
Relationship of VEGF-C* with clinical features
Parameters | VEGF-C | Positive rate (%) | P-value | |
---|---|---|---|---|
| ||||
Positive | Negative | |||
Gender | 0.658 | |||
Male | 18 | 2 | 90.0 | |
Female | 16 | 4 | 80.0 | |
Age | 1.000 | |||
≥ 60 | 20 | 4 | 83.3 | |
< 60 | 14 | 2 | 87.5 | |
Differentiation | 0.027 | |||
Well | 20 | 0 | 100.0 | |
Moderate-poor | 14 | 6 | 70.0 | |
Dukes stage | 0.015 | |||
A + B | 13 | 9 | 59.1 | |
C + D | 16 | 2 | 88.9 | |
Lymphatic metastasis | 0.00014 | |||
With | 15 | 1 | 93.8 | |
Without | 8 | 16 | 33.3 |
VEGF-C: Vascular endothelial growth factor-C.